A Phase 4 interventional study of Midazolam and ketamine in Procedural Pain and Preoperative Anxiety, sponsored by Ibrahim Elabd Hassan Mohamed. Active, not recruiting at 1 site in Egypt. Open to participants aged 2 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Ibrahim Elabd Hassan Mohamed · Phase 4, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Preoperative anxiety in children makes intravenous (IV) cannulation difficult and distressing. This trial compares the success rate of painless IV cannulation among four different oral premedication regimens (Midazolam alone, Ketamine alone, Low-dose combination, and High-dose combination) in pediatric patients.
This is a prospective, randomized, double-blind, controlled trial. Pediatric patients (aged 2-10 years) will be randomized into four equal groups to receive one of four oral premedications 30 minutes before IV cannulation. The primary outcome is the success of painless IV cannulation, assessed using a validated 4-point behavioral scale. Secondary outcomes include sedation depth, parental separation anxiety, fear scores, hemodynamic stability, and adverse events.
245 studies on the registry are indexed under Pain, Procedural; 66 are open to participants now.
This study's planned enrollment of 120 is above the median of 90 across 231 interventional studies indexed under Pain, Procedural.
Browse Pain, Procedural studies →This is the only study on the registry with Ibrahim Elabd Hassan Mohamed as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Oral Midazolam 0.5 mg/kg (maximum 20 mg) administered 30 minutes before IV cannulation
Drug: Midazolam
Oral Ketamine 6 mg/kg administered 30 minutes before IV cannulation
Drug: ketamine
Oral Ketamine 3 mg/kg + Midazolam 0.25 mg/kg administered 30 minutes before IV cannulation.
Drug: Midazolam + Ketamine
Oral Ketamine 6 mg/kg + Midazolam 0.5 mg/kg administered 30 minutes before IV cannulation
Drug: Midazolam + Ketamine
Oral Midazolam 0.5 mg/kg (maximum 20 mg) administered 30 minutes before IV cannulation
Oral Ketamine 6 mg/kg administered 30 minutes before IV cannulation
Drug pages: Midazolam · Ketamine
Oral Ketamine 3 mg/kg + Midazolam 0.25 mg/kg administered 30 minutes before IV cannulation
Drug pages: Midazolam · Ketamine
Oral Ketamine 6 mg/kg + Midazolam 0.5 mg/kg administered 30 minutes before IV cannulation
Success of Painless IV Cannulation
Successful painless IV cannulation is defined as a behavioral score \<= 1 on the 4-Point Behavioral Cannulation Score. Scores range from 0 to 3 (0 = Calm/cooperative, 1 = Mild facial grimacing, 2 = Crying/withdrawal, 3 = Severe crying/resistance). Scores of 0-1 indicate success; 2-3 indicate failure. A lower score indicates a better outcome.
Time frame: At the time of intravenous cannulation (up to 30 minutes after premedication administration)
Parental Separation Anxiety
Assessed using the Parental Separation Anxiety Scale (PSAS). Scores range from 1 to 4 (1 = Easy separation/calm, 4 = Cries and clings to parent). A higher score indicates a worse outcome (higher anxiety)
Time frame: At the time of separation from parents (approximately 30 minutes after premedication)
sedation level
Assessed using the Ramsay Sedation Scale. Scores range from 1 to 6 (1 = Anxious/agitated, 6 = No response to stimuli). A higher score indicates a deeper level of sedation
Time frame: At baseline (before premedication) and at 10, 20, and 30 minutes post-premedication
Anxiety level
Assessed using the Children's Fear Scale (CFS). This is a 5-point scale consisting of five sex-neutral faces ranging from 0 (no fear/neutral) to 4 (extreme fear). A higher score indicates a worse outcome (more anxiety)
Time frame: At the time of intravenous cannulation
Heart Rate (HR)
Heart rate measured in beats per minute (bpm). Significant deviations may represent stress or adverse drug effects.
Time frame: Baseline (before premedication) and every 5 minutes until IV cannulation (up to 30 minutes)
Mean Blood Pressure (MBP)
Mean blood pressure measured in millimeters of mercury (mmHg). Significant deviations may represent stress or adverse drug effects.
Time frame: Baseline (before premedication) and every 5 minutes until IV cannulation (up to 30 minutes)
Oxygen Saturation (SpO2)
Peripheral oxygen saturation measured as a percentage (%).
Time frame: Baseline (before premedication) and every 5 minutes until IV cannulation (up to 30 minutes)
Incidence of Adverse Events
Number of participants experiencing respiratory events (hypoxemia defined as SpO2 \< 90%, apnea), cardiovascular events (bradycardia, hypotension), behavioral events (excessive agitation, paradoxical reactions), or procedure-related events (traumatic cannulation, bleeding). A higher incidence indicates a worse outcome.
Time frame: From premedication administration up to IV cannulation (up to 30 minutes)
Started Jul 2026 (actual). Primary completion is estimated for Jan 2027, 6 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Midazolam · Ketamine